Dömling Alexander PhD.

Journals

CAPRIELLO, I., A. DÖMLING
Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension. ACS Pharmacology & Translational Science. 2026, 9(4), 764-770, ISSN: 2575-9108, PMID: 41988370,  PDF.
VAN DER STRAAT, R., R. OERLEMANS, Y. CONG, J. BOXMA, R. BULAI, C. RIO-BERGE, L. KOEKEMOER, T. ZARGANES-TZITZIKAS, M. GUAN, P. MARPLES, F. REGGIORI, M. GROVES, A. DÖMLING
Ugi-Tetrazole-Derived α‑Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV‑2 3CLpro. ACS Medicinal Chemistry Letters. 2026, 17(4), 856-865, ISSN: 1948-5875, PMID: 41982734,  PDF.
VAN DER STRAAT, R., J. KALINOWSKA-TLUSCIK, K. KURPIEWSKA, A. DÖMLING
Systematic Expansion of an Ugi-Based Multicomponent Synthesis of Tetrasubstituted Imidazoles. ACS Omega. 2026, 11(13), 20889-20894, ISSN: 2470-1343, PMID: 41970876,  PDF.

Postdoctoral mentorship

Reyes Romero Atilio Ph.D.

Accellerated Drug Discovery and Screening

Doctoral mentorship

Guan Zhirui

Discovery and development of novel macrocycles via Multicomponent reactions

Status: Ongoing from 2023.
Capriello Imma

Molecular targets for innovative pharmaceutics

Status: Ongoing from 2023.
Fusco Riccardo

Plasmonic Nanomaterials in Cancer Theranostics

Status: Ongoing from 2023.